BromSite 0.075 % Ophthalmic Solution
RxNorm 1790146
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1790146 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: BromSite 0.075 % Ophthalmic Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Bromfenac 0.75 mg/ML Ophthalmic Solution [Bromsite]
(Atom ID: 8213089)
PSNPrescribable
Prescribable Name (PSN):
BromSite 0.075 % Ophthalmic Solution
(Atom ID: 8213090)
SYPrescribable
Synonym (SY):
Bromsite 0.075 % Ophthalmic Solution
(Atom ID: 8213093)
SYPrescribable
Synonym (SY):
Bromsite 0.75 mg/ML (as bromfenac sodium 0.81 mg/ML) Ophthalmic Solution
(Atom ID: 8213092)
SYPrescribable
Synonym (SY):
Bromsite 0.75 mg/ML Ophthalmic Solution
(Atom ID: 8213091)
Patient Education
Bromfenac Ophthalmic
Bromfenac ophthalmic is used to treat eye swelling and redness (inflammation) and pain that can occur after cataract surgery. Bromfenac ophthalmic is in a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by stopping the release of certain natural substances that cause pain and swelling.
[Learn More]
* Please review the disclaimer below.